Статті для всіх - Andreas Henri DiaconДокладніше
Недоступно ніде: 10
Safety and immunogenicity of the adjunct therapeutic vaccine ID93+ GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo …
TA Day, A Penn-Nicholson, AKK Luabeya, A Fiore-Gartland, N Du Plessis, ...
The Lancet Respiratory Medicine 9 (4), 373-386, 2021
Мандати: Wellcome Trust
Para-aminosalicylic acid: the return of an old friend
PR Donald, AH Diacon
The Lancet infectious diseases 15 (9), 1091-1099, 2015
Мандати: US National Institutes of Health, National Research Foundation, South Africa
Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878–1940
PR Donald, AH Diacon, C Lange, AM Demers, ...
The international journal of tuberculosis and lung disease 22 (9), 972-982, 2018
Мандати: Bill & Melinda Gates Foundation, Helmholtz Association, National Research …
Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments
XA Kayigire, SO Friedrich, L van der Merwe, PR Donald, AH Diacon
Tuberculosis 95 (6), 770-779, 2015
Мандати: National Research Foundation, South Africa
Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial
H Aggerbeck, M Ruhwald, ST Hoff, PN Tingskov, E Hellstrom, ...
The International Journal of Tuberculosis and Lung Disease 23 (1), 38-44, 2019
Мандати: European Commission
Propidium monoazide and Xpert MTB/RIF to quantify Mycobacterium tuberculosis cells
XA Kayigire, SO Friedrich, MN Karinja, L van der Merwe, NA Martinson, ...
Tuberculosis 101, 79-84, 2016
Мандати: National Research Foundation, South Africa
Liquid mycobacterial culture outcomes after different sputum collection techniques before and during treatment
M Lourens, L Philips, CC Kleinhans, SO Friedrich, N Martinson, A Venter, ...
Tuberculosis 116, 17-21, 2019
Мандати: National Research Foundation, South Africa
Safety and Immunogenicity of the H56: IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial
D Tait, A Diacon, ÁH Borges, E van Brakel, D Hokey, KT Rutkowski, ...
The Journal of Infectious Diseases 230 (5), 1262-1270, 2024
Мандати: Bill & Melinda Gates Foundation
Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens
AA Abulfathi, P Assawasuwannakit, PR Donald, AH Diacon, H Reuter, ...
European Journal of Clinical Pharmacology 76, 1557-1565, 2020
Мандати: European & Developing Countries Clinical Trials Partnership
A Partially-Randomised Phase 3 Trial of Pretomanid, Moxifloxacin and Pyrazinamide in Combination for the Treatment of Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis
C Tweed, GH Wills, AM Crook, E Amukoye, V Balanag, AYL Ban, ...
Мандати: Bill & Melinda Gates Foundation, US National Institutes of Health, US Agency …
Доступно в інших місцях: 103
Multidrug-resistant tuberculosis and culture conversion with bedaquiline
AH Diacon, A Pym, MP Grobusch, JM de Los Rios, E Gotuzzo, I Vasilyeva, ...
New England Journal of Medicine 371 (8), 723-732, 2014
Мандати: World Health Organization
Treatment of highly drug-resistant pulmonary tuberculosis
F Conradie, AH Diacon, N Ngubane, P Howell, D Everitt, AM Crook, ...
New England Journal of Medicine 382 (10), 893-902, 2020
Мандати: Bill & Melinda Gates Foundation, US Agency for International Development …
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
DR Tait, M Hatherill, O Van Der Meeren, AM Ginsberg, E Van Brakel, ...
New England Journal of Medicine 381 (25), 2429-2439, 2019
Мандати: Bill & Melinda Gates Foundation, US National Institutes of Health …
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, ...
New England Journal of Medicine 379 (17), 1621-1634, 2018
Мандати: Bill & Melinda Gates Foundation, Department of International Development, UK …
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ...
The Lancet infectious diseases 17 (1), 39-49, 2017
Мандати: UK Medical Research Council, Federal Ministry of Education and Research, Germany
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
MJ Boeree, AH Diacon, R Dawson, K Narunsky, J Du Bois, A Venter, ...
American journal of respiratory and critical care medicine 191 (9), 1058-1065, 2015
Мандати: Bill & Melinda Gates Foundation, UK Medical Research Council
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
JM Bryant, SR Harris, J Parkhill, R Dawson, AH Diacon, P van Helden, ...
The Lancet Respiratory Medicine 1 (10), 786-792, 2013
Мандати: UK Medical Research Council, Wellcome Trust
Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline
AH Diacon, R Dawson, F von Groote-Bidlingmaier, G Symons, A Venter, ...
American journal of respiratory and critical care medicine 191 (8), 943-953, 2015
Мандати: Bill & Melinda Gates Foundation, Department of International Development, UK
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment
SO Friedrich, A Rachow, E Saathoff, K Singh, CD Mangu, R Dawson, ...
The lancet Respiratory medicine 1 (6), 462-470, 2013
Мандати: UK Medical Research Council
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a …
CD Tweed, R Dawson, DA Burger, A Conradie, AM Crook, CM Mendel, ...
The Lancet Respiratory Medicine 7 (12), 1048-1058, 2019
Мандати: Bill & Melinda Gates Foundation, US Agency for International Development …
Дані про публікацію й грошову підтримку визначаються автоматично комп'ютерною програмою